Iambic Therapeutics
Iambic Therapeutics is a biotech company that uses AI to design differentiated drug candidates, with a clinical pipeline targeting HER2, KIF18A, and CDK2/4.
K Health provides health systems with an AI-powered digital front door and virtual care platform, including PatientGPT, to streamline patient intake and expand access to primary and specialty care.
K Health provides health systems with an AI-enabled care platform that combines a patient-facing conversational AI, PatientGPT, with virtual primary and specialty care services. The platform is designed for leading health systems seeking to expand access, streamline intake, and extend clinical capacity without sacrificing safety or brand control.
At the center of K Health's offering is PatientGPT, a conversational AI that acts as a digital front door for both virtual and in-clinic care. Patients describe their symptoms in their own words, and PatientGPT asks follow-up questions similar to an experienced intake nurse. It captures structured intake data, then routes the patient to the appropriate care setting—whether that's a virtual visit, an in-person appointment, or a message to a clinician. The conversation ends with a scheduled visit written back to the electronic medical record (EMR), so patients leave with a clear next step. This dynamic intake process is designed to integrate directly into existing EHR systems, grounding interactions in patient medical records and driving clinical engagement before a visit even begins.
K Health enables 24/7 access to board-certified doctors for acute, chronic, and preventive care. The AI-guided intake handles administrative tasks, allowing physicians to focus on continuous care rather than paperwork. This model supports longitudinal primary care, where patients can establish ongoing relationships with clinicians. The platform is built to identify when a patient needs human care and route them to the appropriate care team, ensuring that AI does not act alone. Clinicians set the guardrails and receive every escalation, maintaining a human-in-the-loop approach.
Beyond primary care, K Health supports integrated virtual care for specialties such as endocrinology and dermatology. This extends a health system's network capacity by providing continuous, specialized support. For example, a patient with diabetes can receive between-visit coaching and check-ins, while someone with a skin condition can consult a dermatologist virtually. The platform is designed to be configurable around a health system's care destinations, policies, and escalation pathways, so specialty care remains connected to the broader care continuum.
Safety is a foundational element of K Health's platform. Every conversation is measured, checked, and backed by clinicians. The clinical foundation has been published in peer-reviewed journals, including Annals of Internal Medicine and Mayo Clinic Proceedings. An automated evaluator, called the Judge, scores conversations against a health system's policy document and provides a pass or fail, the clause involved, and a plain-language reason. This creates an auditable record that the care delivered matches the care intended. Performance is reported in a manner similar to autonomous-vehicle programs—normalized per thousand conversations—so it can be compared over time and across sites.
Health systems deploy PatientGPT for a range of tasks. It can guide patients to the right service or provider, manage in-basket messages by drafting and triaging them for clinician review, and support weight management programs with ongoing coaching. It also helps close care gaps by flagging overdue screenings and labs, supports chronic condition management for diabetes and hypertension, and assists with appointment scheduling and triage. Medication adherence is another focus, with refill reminders and support for staying on treatment plans. Patient education is available around the clock, answering questions in plain language.
K Health partners with leading health systems, including Mass General Brigham, Hartford HealthCare, Mayo Clinic, Northwell Health, Cedars-Sinai Connect, Hackensack Meridian Health, Penn Medicine Princeton Health, and Novant Health. These partnerships reflect a shared goal of using AI to improve responsiveness, gather better information, and enhance care. The platform is designed to connect to patient experiences and systems of record, though specific integrations depend on each health system's technical environment and implementation plan. K Health works with partners to address security, privacy, and compliance requirements as part of implementation.
PatientGPT runs under the health system's brand, with its own clinicians, care destinations, and policies. Patients stay inside the health system's experience from the first message to the booked visit. The AI holds a real conversation, handling vague, overlapping, and changing symptoms without relying on a rigid decision tree. This configurability allows health systems to tailor the platform to their specific workflows and patient populations, ensuring that the AI supports rather than disrupts existing care models.
Subscription pricing is not listed.
Features, pricing and availability may change. Always verify details on the official website. Maintained by steven · Last updated Oct 16, 2026 →
Iambic Therapeutics is a biotech company that uses AI to design differentiated drug candidates, with a clinical pipeline targeting HER2, KIF18A, and CDK2/4.
Microsoft for Healthcare brings Dragon Copilot, Dragon Medical One, and PowerMic Mobile to clinicians, combining speech recognition and an AI clinical assistant to streamline documentation and clinical tasks.
Notable is a healthcare automation platform that deploys AI agents across patient access, revenue cycle, care operations, and contact center work. It is built for health systems, health plans, and provider organizations that want to reduce administrative load without adding staff.
IQVIA provides life sciences organizations with data, analytics, and technology to accelerate innovation, improve patient outcomes, and bring treatments to market faster.